Nonprofit Born From Ashes of 23andMe Hires Former Pfizer Heavyweight as GC

The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

Regeneron Pharmaceuticals: Is Wall Street Finally Paying Attention?

So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...

23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer

PALO ALTO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, ...